Nuvation Bio Inc.
NUVB
$2.88
-$0.02-0.69%
NYSE
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Net Income | -202.90M | -606.38M | -567.94M | -532.28M | -510.72M |
Total Depreciation and Amortization | 1.05M | 935.00K | 683.00K | 519.00K | 412.00K |
Total Amortization of Deferred Charges | 18.00K | -- | -- | -- | -- |
Total Other Non-Cash Items | 32.46M | 453.25M | 449.35M | 439.82M | 436.44M |
Change in Net Operating Assets | 1.18M | -5.14M | -12.51M | -7.20M | -10.35M |
Cash from Operations | -168.19M | -157.34M | -130.41M | -99.14M | -84.21M |
Capital Expenditure | -388.00K | -207.00K | -162.00K | -188.00K | -62.00K |
Sale of Property, Plant, and Equipment | -- | -- | -- | 14.00K | 14.00K |
Cash Acquisitions | -92.00K | 12.43M | 12.43M | 12.52M | 12.52M |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | 190.43M | 157.12M | 110.44M | 91.75M | 52.91M |
Cash from Investing | 189.95M | 169.34M | 122.70M | 104.09M | 65.39M |
Total Debt Issued | 54.48M | 12.61M | 12.61M | 7.04M | 7.04M |
Total Debt Repaid | -11.54M | -17.70M | -17.16M | -9.53M | -6.32M |
Issuance of Common Stock | 5.21M | 5.95M | 4.89M | 3.85M | 2.25M |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | 143.39M | -- | -- | -- | -- |
Cash from Financing | 191.53M | 858.00K | 331.00K | 1.35M | 2.97M |
Foreign Exchange rate Adjustments | 398.00K | 604.00K | 453.00K | -664.00K | 78.00K |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 213.69M | 13.47M | -6.93M | 5.64M | -15.78M |